X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EXPERT REVIEWS IN MOLECULAR MEDICINE

期刊標題檢索 EXPERT REV MOL 最新評論: Please translate the following paragraph into English and Japanese, a... (2024-04-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EXPERT REVIEWS IN MOLECULAR MEDICINE]您好,您是該頁面的第 17237 位訪客。

期刊簡介
期刊名稱EXPERT REVIEWS IN MOLECULAR MEDICINE EXPERT REVIEWS IN MOLECULAR MEDICINE
LetPub Score
7.4
50 ratings
Rate

Reputation
8.8

Influence
6.3

Speed
7.0

期刊簡稱EXPERT REV MOL MED
ISSN1462-3994
h-index73
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.401.3570.977
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q259 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q2148 / 410

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Expert Reviews in Molecular Medicine is an innovative online journal featuring authoritative and timely Reviews covering gene therapy, immunotherapeutics, drug design, vaccines, genetic testing, pathogenesis, microbiology, genomics, molecular epidemiology and diagnostic techniques. We especially welcome reviews on translational aspects of molecular medicine, particularly those related to the application of new understanding of the molecular basis of disease to experimental medicine and clinical practice.
官方網站http://journals.cambridge.org/action/displayAbstract?aid=9255457
在線稿件提交https://www.editorialmanager.com/ERMM
開放訪問No
出版商Cambridge University Press
主題領域BIOCHEMISTRY & MOLECULAR BIOLOGY
出版國/地區ENGLAND
發行頻率不定期刊行
創刊年1997
每年文章數25每年文章數趨勢
黃金OA百分比31.63%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ176/313
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ252/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-3994%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Invited contributions ? Irregular
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【EXPERT REVIEWS IN MOLECULAR MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science Translational MedicineH-index: 168

    CiteScore: 26.70
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    Wiley Interdisciplinary Reviews-Nanomedicine and NanobiotechnologyH-index: 0

    CiteScore: 17.60
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 108

    CiteScore: 11.50
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    American Journal of Translational ResearchH-index: 45

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International398129
    Science Translational Medicine170707
    American Journal of Translational Research165370
    Stem Cell Research & Therapy136208
    Frontiers of Medicine89266
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE78945
    Journal of Diabetes Research56540
    Journal of Cardiovascular Translational Research32185
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology30807
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION16000
  •  

    EXPERT REVIEWS IN MOLECULAR MEDICINE EXPERT REVIEWS IN MOLECULAR MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [EXPERT REVIEWS IN MOLECULAR MEDICINE] 的評論撰寫評論
作者: 孤云悦弘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-03 16:25:03 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as the titles
(0) 讚! | 孤云悦弘

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [EXPERT REVIEWS IN MOLECULAR MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*